For a more in-depth look at this topic, you may be interested in participating in the first masterclass of our Healthtech Reimbursement Program – Healthtech reimbursement: getting paid in the USA.
What’s driving the US healthcare market and how can companies position for opportunity?
Mr Edward Black, Director, Global Reimbursement Strategy, NAMSA, will take a look at the state of health care policy in the US over the course of the past 10 years with a look forward to the next decade. Edward will also compare the cost and perceived quality of healthcare in the US compared to other major global markets, including Australia.
This seminar will explore international health care quality rankings; the evolution of health policy in the US as it affects medical technologies; fee-for-service medicine; Obama Care; Trump Care; and “Medicare for All”.
Date: Tuesday 25 June
Time: 3.45 pm registration, presentation & discussion 4.00 pm – 5.00 pm, followed by networking until 6.00 pm
Venue: KPMG, Level 36, Tower Two, 727 Collins Street, Docklands
BioMelbourne Network Members: $65 (incl. GST)
Non Members: $130 (incl. GST)
Note: Participants registered for the first masterclass of the Healthtech Reimbursement program will receive three registrations for this event.
A full refund is given up to 7 days prior to the event. No refunds within 7 days of the event.
Edward Black joined NAMSA in 2019 to build a Global Reimbursement Department after founding his own company in 2008. Prior to that he worked for over 25 years in medical management and hospital and physician relations within the Blue Cross Blue Shield system and served on two national advisory boards responsible for driving consistency in medical, benefit, and payment policy across the Blue Cross system. From 1994 to 2002, Mr Black served as the executive director of three managed care business partnerships with large multispecialty clinics for which he was awarded the 1995 Outstanding Contribution to the Healthcare Industry citation by Medical Alley Association.
Mr Black has an MBA and is active in several global medical technology initiatives and is a frequent international lecturer. He is an adjunct faculty member in the University of Minnesota Master of Science in Medical Device Innovation Program and Reimbursement Advisor to the University of Minnesota Office for Technology Commercialization and the National University of Ireland-Galway BioExel and BioInnovate medical technology accelerators.